世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000039134

敗血症診断薬の世界市場:規模と動向、COVID-19の影響、2029年までの予測

Daedal Research

Global Sepsis Diagnostics Market: Size and Trends with Impact of COVID-19 and Forecast up to 2029

発刊日 2024/07

言語英語

体裁PDF/205ページ

ライセンス/価格205ページ

0000039134

Single 2,450USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

世界の敗血症診断市場:技術別、製品別、方法別、病原体の種類別、検査タイプ別、エンドユーザー別、地域規模別、COVID-19の影響と2029年までの予測

世界の敗血症診断薬市場は2023年に8億3,540万ドルと評価されました。市場価値は2029年までに13億9000万ドルに達すると予想されます。敗血症診断は、医学研究とヘルスケアの重要な分野であり、感染に対する体の極端な反応によって引き起こされる生命を脅かす状態である敗血症をタイムリーかつ正確に特定することに焦点を当てています。この反応は、迅速に治療しないと、組織の損傷、臓器不全、および死につながる可能性があります。 今後数年間、世界の敗血症診断市場は、医療インフラの改善に向けた持続的な努力、継続的な技術の進歩、敗血症に対する意識の高まりにより、成長軌道を継続すると予想されます。特に遠隔地やサービスの行き届いていない地域でのポイントオブケア検査の採用が拡大していることは、医療リソースが限られている環境でのタイムリーな診断と治療を可能にすることで、市場の成長をさらに促進します。さらに、研究とイノベーションへの継続的な注力と、医療提供者、診断会社、研究機関間の戦略的な協力関係が、次世代の診断ツールの開発に貢献し、今後数年間の市場の堅調な拡大を確実にします。市場は、2024年から2029年の予測期間中に約9%のCAGRで成長すると予想されます。

レポート詳細

目次

Table of Contents

1. Executive Summary

2. Introduction

2.1 Sepsis Diagnostics: An Overview
2.1.1 Introduction to Sepsis Diagnostics
2.1.2 Symptoms of Sepsis

2.2 Sepsis Diagnostics Segmentation: An Overview

3. Global Market Analysis

3.1 Global Sepsis Diagnostics Market: An Analysis

3.1.1 Global Sepsis Diagnostics Market: An Overview
3.1.2 Global Sepsis Diagnostics Market by Value
3.1.3 Global Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, and Others)
3.1.4 Global Sepsis Diagnostics Market by Product (Blood Culture Media, Instruments, Assays & Reagents, and Software)
3.1.5 Global Sepsis Diagnostics Market by Method (Conventional Diagnostics and Automated Diagnostics)
3.1.6 Global Sepsis Diagnostics Market by Pathogen Type (Bacterial Sepsis, Fungal Sepsis, and Other Pathogen)
3.1.7 Global Sepsis Diagnostics Market by Test Type (Laboratory Tests and Point-of-Care Tests)
3.1.8 Global Sepsis Diagnostics Market by End-User (Hospitals, Pathology & Reference Laboratories, and Research Institutes and Others)
3.1.9 Global Sepsis Diagnostics Market by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

3.2 Global Sepsis Diagnostics Market: Technology Analysis

3.2.1 Global Sepsis Diagnostics Market by Technology: An Overview
3.2.2 Global Microbiology Sepsis Diagnostics Market by Value
3.2.3 Global Molecular Sepsis Diagnostics Market by Value
3.2.4 Global Molecular Sepsis Diagnostics Market by Type (Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, and Microarrays)
3.2.5 Global Molecular Sepsis Diagnostics Market Type by Value
3.2.6 Global Immunoassays Sepsis Diagnostics Market by Value
3.2.7 Global Flow Cytometry Sepsis Diagnostics Market by Value
3.2.8 Global Others Sepsis Diagnostics Market by Value

3.3 Global Sepsis Diagnostics Market: Product Analysis

3.3.1 Global Sepsis Diagnostics Market by Product: An Overview
3.3.2 Global Sepsis Diagnostics Blood Culture Media Market by Value
3.3.3 Global Sepsis Diagnostics Instruments Market by Value
3.3.4 Global Sepsis Diagnostics Assays & Reagents Market by Value
3.3.5 Global Sepsis Diagnostics Software Market by Value

3.4 Global Sepsis Diagnostics Market: Method Analysis

3.4.1 Global Sepsis Diagnostics Market by Method: An Overview
3.4.2 Global Conventional Sepsis Diagnostics Market by Value
3.4.3 Global Automated Sepsis Diagnostics Market by Value

3.5 Global Sepsis Diagnostics Market: Pathogen Type Analysis

3.5.1 Global Sepsis Diagnostics Market by Pathogen Type: An Overview
3.5.2 Global Bacterial Sepsis Diagnostics Market by Value
3.5.3 Global Fungal Sepsis Diagnostics Market by Value
3.5.4 Global Other Pathogen Sepsis Diagnostics Market by Value

3.6 Global Sepsis Diagnostics Market: Test Type Analysis

3.6.1 Global Sepsis Diagnostics Market by Test Type: An Overview
3.6.2 Global Laboratory Sepsis Diagnostics Tests Market by Value
3.6.3 Global Point-of-Care Sepsis Diagnostics Tests Market by Value

3.7 Global Sepsis Diagnostics Market: End-User Analysis

3.7.1 Global Sepsis Diagnostics Market by End-User: An Overview
3.7.2 Global Sepsis Diagnostics Hospitals Market by Value
3.7.3 Global Sepsis Diagnostics Pathology & Reference Laboratories Market by Value
3.7.4 Global Sepsis Diagnostics Research Institutes and Others Market by Value

4. Regional Market Analysis

4.1 North America Sepsis Diagnostics Market: An Analysis

4.1.1 North America Sepsis Diagnostics Market: An Overview
4.1.2 North America Sepsis Diagnostics Market by Value
4.1.3 North America Sepsis Diagnostics Market by Region (The US, Canada, and Mexico)
4.1.4 The US Sepsis Diagnostics Market by Value
4.1.5 The US Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, and Others)
4.1.6 The US Sepsis Diagnostics Market by Product (Blood Culture Media, Instruments, Assays & Reagents, and Software)
4.1.7 The US Sepsis Diagnostics Market by Method (Conventional Diagnostics and Automated Diagnostics)
4.1.8 The US Sepsis Diagnostics Market by Pathogen Type (Bacterial Sepsis, Fungal Sepsis, and Other Pathogen)
4.1.9 The US Sepsis Diagnostics Market by Test Type (Laboratory Tests and Point-of-Care Tests)
4.1.10 The US Sepsis Diagnostics Market by End-User (Hospitals, Pathology & Reference Laboratories, and Research Institutes and Others)
4.1.11 Canada Sepsis Diagnostics Market by Value
4.1.12 Mexico Sepsis Diagnostics Market by Value

4.2 Europe Sepsis Diagnostics Market: An Analysis

4.2.1 Europe Sepsis Diagnostics Market: An Overview
4.2.2 Europe Sepsis Diagnostics Market by Value
4.2.3 Europe Sepsis Diagnostics Market by Region (Germany, The UK, France, Italy, Spain, and Rest of the Europe)
4.2.4 Germany Sepsis Diagnostics Market by Value
4.2.5 The UK Sepsis Diagnostics Market by Value
4.2.6 France Sepsis Diagnostics Market by Value
4.2.7 Italy Sepsis Diagnostics Market by Value
4.2.8 Spain Sepsis Diagnostics Market by Value
4.2.9 Rest of Europe Sepsis Diagnostics Market by Value

4.3 Asia Pacific Sepsis Diagnostics Market: An Analysis

4.3.1 Asia Pacific Sepsis Diagnostics Market: An Overview
4.3.2 Asia Pacific Sepsis Diagnostics Market by Value
4.3.3 Asia Pacific Sepsis Diagnostics Market by Region (China, Japan, India, and Rest of the Asia Pacific)
4.3.4 China Sepsis Diagnostics Market by Value
4.3.5 Japan Sepsis Diagnostics Market by Value
4.3.6 India Sepsis Diagnostics Market by Value
4.3.7 Rest of Asia Pacific Sepsis Diagnostics Market by Value

4.4 Latin America Sepsis Diagnostics Market: An Analysis

4.4.1 Latin America Sepsis Diagnostics Market: An Overview
4.4.2 Latin America Sepsis Diagnostics Market by Value

4.5 Middle East & Africa Sepsis Diagnostics Market: An Analysis

4.5.1 Middle East & Africa Sepsis Diagnostics Market: An Overview
4.5.2 Middle East & Africa Sepsis Diagnostics Market by Value

5. Impact of COVID-19

5.1 Impact of COVID-19 on Global Sepsis Diagnostics Market
5.2 Post COVID-19 Impact on Global Sepsis Diagnostics Market

6. Market Dynamics

6.1 Growth Drivers
6.1.1 Aging Population
6.1.2 Rising Healthcare Expenditure
6.1.3 Growing Government Initiatives for Creating Sepsis Awareness
6.1.4 Increasing Incidence of Hospital-acquired Infections (HAIs)
6.1.5 Rising Number of Sepsis Cases
6.1.6 Increase in Funding and Support for Sepsis Diagnostics Research
6.1.7 Surging Collaboration and Partnerships
6.1.8 Regulatory Approvals and Reimbursement Policies

6.2 Challenges
6.2.1 High Cost of Automated Diagnostic Devices
6.2.2 Lack of Skilled Professionals

6.3 Market Trends
6.3.1 Development of Rapid Diagnostic Tests
6.3.2 Increasing Availability of Point-of-Care Diagnostic Tools
6.3.3 Integration of Artificial Intelligence (AI) and Machine Learning (ML)
6.3.4 Increasing Use of Biomarker-Based Diagnostics
6.3.5 Rising Technological Advancements in Sepsis Diagnosis
6.3.6 Integration of Electronic Health Records (EHR)

7. Competitive Landscape

7.1 Global Sepsis Diagnostics Market: Competitive Landscape
7.2 Global Sepsis Diagnostics Market Players: Product Comparison

8. Company Profiles

8.1 BioMerieux SA
8.1.1 Business Overview
8.1.2 Revenue by Technology and Application
8.1.3 Business Strategy

8.2 Abbott Laboratories
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategy

8.3 Danaher Corporation (Beckman Coulter Inc.)
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategy

8.4 Thermo Fisher Scientific Inc.
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategy

8.5 F. Hoffmann-La Roche Ltd
8.5.1 Business Overview
8.5.2 Sales by Operating Business
8.5.3 Business Strategy

8.6 Becton, Dickinson and Company
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategy

8.7 Koninklijke Philips NV
8.7.1 Business Overview
8.7.2 Operating Segments
8.7.3 Business Strategy

8.8 Siemens Healthineers AG
8.8.1 Business Overview
8.8.2 Operating Segments
8.8.3 Business Strategy

8.9 DiaSorin (Luminex Corporation)
8.9.1 Business Overview
8.9.2 Operating Segments
8.9.3 Business Strategy

8.10 Bruker Corporation
8.10.1 Business Overview
8.10.2 Operating Segments
8.10.3 Business Strategy

8.11 T2 Biosystems, Inc.
8.11.1 Business Overview
8.11.2 Revenue by Source
8.11.3 Business Strategy

8.12 Immunexpress, Pty Ltd
8.12.1 Business Overview
8.12.2 Business Strategy

List of Figures
Figure 1: Symptoms of Sepsis
Figure 2: Sepsis Diagnostics Segmentation
Figure 3: Global Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 4: Global Sepsis Diagnostics Market by Value; 2024-2029 (US$ Billion)
Figure 5: Global Sepsis Diagnostics Market by Technology; 2023 (Percentage, %)
Figure 6: Global Sepsis Diagnostics Market by Product; 2023 (Percentage, %)
Figure 7: Global Sepsis Diagnostics Market by Method; 2023 (Percentage, %)
Figure 8: Global Sepsis Diagnostics Market by Pathogen Type; 2023 (Percentage, %)
Figure 9: Global Sepsis Diagnostics Market by Test Type; 2023 (Percentage, %)
Figure 10: Global Sepsis Diagnostics Market by End-User; 2023 (Percentage, %)
Figure 11: Global Sepsis Diagnostics Market by Region; 2023 (Percentage, %)
Figure 12: Global Microbiology Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 13: Global Microbiology Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 14: Global Molecular Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 15: Global Molecular Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 16: Global Molecular Sepsis Diagnostics Market by Type; 2023 (Percentage, %)
Figure 17: Global Molecular Sepsis Diagnostics Market Type by Value; 2019-2023 (US$ Million)
Figure 18: Global Molecular Sepsis Diagnostics Market Type by Value; 2024-2029 (US$ Million)
Figure 19: Global Immunoassays Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 20: Global Immunoassays Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 21: Global Flow Cytometry Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 22: Global Flow Cytometry Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 23: Global Others Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 24: Global Others Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 25: Global Sepsis Diagnostics Blood Culture Media Market by Value; 2019-2023 (US$ Million)
Figure 26: Global Sepsis Diagnostics Blood Culture Media Market by Value; 2024-2029 (US$ Million)
Figure 27: Global Sepsis Diagnostics Instruments Market by Value; 2019-2023 (US$ Million)
Figure 28: Global Sepsis Diagnostics Instruments Market by Value; 2024-2029 (US$ Million)
Figure 29: Global Sepsis Diagnostics Assays & Reagents Market by Value; 2019-2023 (US$ Million)
Figure 30: Global Sepsis Diagnostics Assays & Reagents Market by Value; 2024-2029 (US$ Million)
Figure 31: Global Sepsis Diagnostics Software Market by Value; 2019-2023 (US$ Million)
Figure 32: Global Sepsis Diagnostics Software Market by Value; 2024-2029 (US$ Million)
Figure 33: Global Conventional Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 34: Global Conventional Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 35: Global Automated Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 36: Global Automated Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 37: Global Bacterial Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 38: Global Bacterial Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 39: Global Fungal Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 40: Global Fungal Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 41: Global Other Pathogen Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 42: Global Other Pathogen Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 43: Global Laboratory Sepsis Diagnostics Tests Market by Value; 2019-2023 (US$ Million)
Figure 44: Global Laboratory Sepsis Diagnostics Tests Market by Value; 2024-2029 (US$ Million)
Figure 45: Global Point-of-Care Sepsis Diagnostics Tests Market by Value; 2019-2023 (US$ Million)
Figure 46: Global Point-of-Care Sepsis Diagnostics Tests Market by Value; 2024-2029 (US$ Million)
Figure 47: Global Sepsis Diagnostics Hospitals Market by Value; 2019-2023 (US$ Million)
Figure 48: Global Sepsis Diagnostics Hospitals Market by Value; 2024-2029 (US$ Million)
Figure 49: Global Sepsis Diagnostics Pathology & Reference Laboratories Market by Value; 2019-2023 (US$ Million)
Figure 50: Global Sepsis Diagnostics Pathology & Reference Laboratories Market by Value; 2024-2029 (US$ Million)
Figure 51: Global Sepsis Diagnostics Research Institutes and Others Market by Value; 2019-2023 (US$ Million)
Figure 52: Global Sepsis Diagnostics Research Institutes and Others Market by Value; 2024-2029 (US$ Million)
Figure 53: North America Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 54: North America Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 55: North America Sepsis Diagnostics Market by Region; 2023 (Percentage, %)
Figure 56: The US Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 57: The US Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million) Figure 58: The US Sepsis Diagnostics Market by Technology; 2023 (Percentage, %)
Figure 59: The US Sepsis Diagnostics Market by Product; 2023 (Percentage, %)
Figure 60: The US Sepsis Diagnostics Market by Method; 2023 (Percentage, %)
Figure 61: The US Sepsis Diagnostics Market by Pathogen Type; 2023 (Percentage, %)
Figure 62: The US Sepsis Diagnostics Market by Test Type; 2023 (Percentage, %)
Figure 63: The US Sepsis Diagnostics Market by End-User; 2023 (Percentage, %)
Figure 64: Canada Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 65: Canada Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 66: Mexico Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 67: Mexico Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 68: Europe Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 69: Europe Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 70: Europe Sepsis Diagnostics Market by Region; 2023 (Percentage, %)
Figure 71: Germany Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 72: Germany Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 73: The UK Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 74: The UK Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 75: France Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 76: France Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 77: Italy Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 78: Italy Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 79: Spain Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 80: Spain Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 81: Rest of Europe Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 82: Rest of Europe Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 83: Asia Pacific Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 84: Asia Pacific Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 85: Asia Pacific Sepsis Diagnostics Market by Region; 2023 (Percentage, %)
Figure 86: China Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 87: China Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 88: Japan Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 89: Japan Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 90: India Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 91: India Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 92: Rest of Asia Pacific Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 93: Rest of Asia Pacific Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 94: Latin America Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 95: Latin America Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 96: Middle East & Africa Sepsis Diagnostics Market by Value; 2019-2023 (US$ Million)
Figure 97: Middle East & Africa Sepsis Diagnostics Market by Value; 2024-2029 (US$ Million)
Figure 98: Global Percentage of Population Aged 65 Years or Above; 2018-2023 (Percentage, %)
Figure 99: Global Healthcare Expenditure as a Share of GDP; 2018-2023 (Percentage, %)
Figure 100: BioMerieux SA Revenue by Technology and Application; 2023 (Percentage, %)
Figure 101: Abbott Laboratories Revenue by Segment; 2023 (Percentage, %)
Figure 102: Danaher Corporation Revenue by Segment; 2023 (Percentage, %)
Figure 103: Thermo Fisher Scientific Inc. Revenue by Segment; 2023 (Percentage, %)
Figure 104: F. Hoffmann-La Roche Ltd Sales by Operating Business; 2023 (Percentage, %)
Figure 105: Becton, Dickinson and Company Revenues by Segment; 2023 (Percentage, %)
Figure 106: Koninklijke Philips NV Sales by Segments; 2023 (Percentage, %)
Figure 107: Siemens Healthineers AG Revenue by Segment; 2023 (Percentage, %)
Figure 108: DiaSorin Net Revenues by Segment; 2023 (Percentage, %)
Figure 109: Bruker Corporation Revenue by Segment; 2023 (Percentage, %)
Figure 110: T2 Biosystems, Inc. Revenue by Source; 2023 (Percentage, %)
Table 1: Government Initiatives for Creating Sepsis Awareness
Table 2: Global Sepsis Diagnostics Market Players: Product Comparison

この商品のレポートナンバー

0000039134

TOP